Legend Biotech Corporation American Depositary Shares Earnings Dividend

Legend Biotech Corporation American Depositary Shares’s revenue jumped 51.93% since last year same period to $387.5Mn in the Q2 2026. On a quarterly growth basis, Legend Biotech Corporation American Depositary Shares has generated 27.01% jump in its revenue since last 3-months.

Legend Biotech Corporation American Depositary Shares’s net profit jumped 126.48% since last year same period to $33.2Mn in the Q2 2026. On a quarterly growth basis, Legend Biotech Corporation American Depositary Shares has generated 161.14% jump in its net profits since last 3-months.

Legend Biotech Corporation American Depositary Shares’s net profit margin jumped 117.43% since last year same period to 8.57% in the Q2 2026. On a quarterly growth basis, Legend Biotech Corporation American Depositary Shares has generated 148.14% jump in its net profit margins since last 3-months.

Legend Biotech Corporation American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at 0.12 - a 710.81% jump from last quarter’s estimates.

Legend Biotech Corporation American Depositary Shares’s earning per share (EPS) estimates for the current year stand at 0.12.

Legend Biotech Corporation American Depositary Shares’s earning per share (EPS) jumped 113.24% since last year same period to 0.09 in the Q2 2026. This indicates that the Legend Biotech Corporation American Depositary Shares has generated 113.24% annual rate of jump in its earning per share (EPS) in the last 4 quarters.